Nadezhda A. Kuznetsova

Moscow, MOW 123098, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain.

Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain.

Journal: Vaccines
Published: November 29, 2025

Ubiquitous Expression of mPolgmut Leads to the Accumulation of Cytotoxic CD8+ T Lymphocytes in Young Mice.

Ubiquitous Expression of mPolgmut Leads to the Accumulation of Cytotoxic CD8+ T Lymphocytes in Young Mice.

Journal: Life (Basel, Switzerland)
Published: October 23, 2025

Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain

Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain

Journal: Voprosy virusologii
Published: October 14, 2025

Mutations in Filamin C Associated with Both Alleles Do Not Affect the Functioning of Mice Cardiac Muscles.

Mutations in Filamin C Associated with Both Alleles Do Not Affect the Functioning of Mice Cardiac Muscles.

Journal: International journal of molecular sciences
Published: November 14, 2024

Study of the influence of population immunity to tick-borne encephalitis virus on the characteristics of the epidemic process in Russia.

Study of the influence of population immunity to tick-borne encephalitis virus on the characteristics of the epidemic process in Russia.

Journal: Frontiers in immunology
Published: November 09, 2024

Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models.

Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models.

Journal: Vaccines
Published: September 17, 2024

The Molecular and Biological Patterns Underlying Sustained SARS-CoV-2 Circulation in the Human Population

The Molecular and Biological Patterns Underlying Sustained SARS-CoV-2 Circulation in the Human Population

Journal: Voprosy virusologii
Published: June 16, 2024

Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.

Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.

Journal: Vaccines
Published: February 07, 2024

Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response.

Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response.

Journal: Frontiers in immunology
Published: February 03, 2024

New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.

New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.

Journal: Antiviral research
Published: January 31, 2024

Alginate Gel Encapsulated with Enzybiotics Cocktail Is Effective against Multispecies Biofilms.

Alginate Gel Encapsulated with Enzybiotics Cocktail Is Effective against Multispecies Biofilms.

Journal: Gels (Basel, Switzerland)
Published: December 12, 2023

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1.

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1.

Journal: Vaccines
Published: August 10, 2023
Showing 1-12 of 27

Last Updated: 09/26/2026